The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: Implications for benzene-induced hematopoietic toxicity

Chemico-Biological Interactions

Volumn 184, Issue 1-2, 2010, Pages 246-251

  Gasiewicz, Thomas A ^a   Singh, Kameshwar P ^a   Casado, Fanny L ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Aryl hydrocarbon receptor; Benzene; Hematopoietic stem cells

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; BENZENE;

AGING; BONE MARROW TOXICITY; CELL ACTIVITY; CELL CYCLE REGULATION; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CELL STRESS; DRUG SENSITIVITY; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKEMIA; LIFESPAN; LYMPHOMA; NONHUMAN; NULL ALLELE; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BENZENE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; RECEPTORS, ARYL HYDROCARBON;

ANIMALIA; MUS;

EID: 77950630137     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.10.019     Document Type: Review

References (87)

1. Snyder R. Overview of the toxicology of benzene. J. Toxicol. Environ. Health, Part A 2000, 61:339-346.
2. Snyder R. Benzene's toxicity: a consolidated short review of human and animal studies by HA Khan. Hum. Exp. Toxicol. 2007, 26:687-696.
3. Lutz W.K., Schlatter C. Mechanism of the carcinogenic action of benzene: irreversible binding to rat liver DNA. Chem. Biol. Interact. 1977, 18:241-245.
4. Subrahmanyam V.V., Ross D., Eastmond D.A., Smith M.T. Potential role of free radicals in benzene-induced myelotoxicty and leukemia. Free Radic. Biol. 1991, 11:495-515.
5. Eastmond D.A., Smith M.T., Irons R.D. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 1987, 91:85-95.
6. Brunmark A., Cadenas E. Reductive addition of glutathione to p-benzoquinone, 2-hydroxy-p-benzoquinone, p-benzoquinone epoxides. Effect of the hydroxyl- and glutathionyl substituents on p-benzoquinone autooxidation. Chem. Biol. Interact. 1988, 68:273-298.
7. Yoon B., Hirabayashi Y., Kawasaki Y., Kodama Y., Kaneko T., Kanno J., Kim D., Fujii-Kuriyama Y., Inoue T. Aryl hydrocarbon receptor mediates benzene-induced hematotoxicity. Toxicol. Sci. 2002, 70:150-156.
8. Hirabayashi Y., Yoon B., Li G.-X., Fujii-Kuriyama Y., Kaneko T., Kanno J., Inoue T. Benzene-induced hematopoietic toxicity transmitted by AhR in wild-type mouse and nullified by repopulation with AhR-deficient bone marrow cells: time after benzene treatment and recovery. Chemosphere 2008, 73:S290-S294.
9. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 2000, 59:65-85.
10. Bauer A.K., Faiola B., Abernethy D.J., Marchan R., Pluta L.J., Wong V.A., Gonzalez F.J., Butterworth B.E., Borghoff S.J., Everitt J.I., Recio L. Male mice deficient in microsomal epoxide hydrolase are not susceptible to benzene-induced toxicity. Toxicol. Sci. 2003, 72:201-209.
11. Hirabayashi Y., Miyajima A., Yokota T., Arai K.-I., Li G.-X., Yoon B.I., Kaneko T., Kanno J., Inoue T. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on B cell differentiation in mouse pre-B colonization model regulated by artificially introduced human IL-3 receptors. Organohalogen Comd. 2002, 55:359-362.
12. van Grevenynghe J., Bernard M., Langouet S., Le Berre C., Fest T., Fardel O. Human CD34-positive hematopoietic stem cells constitute targets for carcinogenic polycyclic aromatic hydrocarbons. J. Pharmacol. Exp. Ther. 2005, 314:693-702.
13. Singh K.P., Wyman A., Casado F.L., Garrett R.W., Gasiewicz T.A. Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells. Carcinogenesis 2009, 30:11-19.
14. Ivanova N.B., Dimos J.T., Schaniel C., Hackney J.A., Moore K.A., Lemischka I.R. A stem cell molecular signature. Science 2002, 298:601-604.
15. Favreau L.V., Pickett C.B. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J. Biol. Chem. 1991, 266:4556-4561.
16. Rushmore T.H., Pickett C.B. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. J. Biol. Chem. 1990, 265:14648-14653.
17. Recio L., Bauer A., Faiola B. Use of genetically modified mouse models to assess pathways of benzene-induced bone marrow cytotoxicity and genotoxicity. Chem. Biol. Interact. 2005, 153-154:159-164.
18. Lan Q., Zhang L., Li G., Vermeulen R., Weinberg R.S., Dosemeci M., Rappaport S.M., Shen M., Alter B.P., Wu Y., Kopp W., Waidyanatha S., Rabkin C., Guo W., Chanock S., Hayes R.B., Linet M., Kim S., Yin S., Rothman N., Smith M.T. Hematotoxicity in workers exposed to low levels of benzene. Science 2004, 306:1774-1776.
19. Wan J., Shi J., Hui L., Wu D., Jin X., Zhao N., Huang W., Xia Z., Hu G. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSST1 genes with benzene poisoning. Environ. Health Perspect. 2002, 110:1213-1218.
20. Badham H.J., Winn L.M. Investigating the role of the aryl hydrocarbon receptor in benzene-initiated toxicity in vitro. Toxicology 2007, 229:177-185.
21. Fernandez-Salguero P., Pineau T., Hilbert D.M., McPhail T., Lee S.S., Kimura S., Nebert D.W., Rudikoff S., Ward J.M., Gonzalez F.J. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995, 268:722-726.
22. Schmidt J.V., Su G.H., Reddy J.K., Simon M.C., Bradfield C.A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:6731-6736.
23. Fernandez-Salguero P.M., Ward J.M., Sundberg J.P., Gonzalez F.J. Lesions of aryl hydrocarbon receptor-deficient mice. Vet. Pathol. 1997, 34:605-614.
24. Lahvis G.P., Pyzalski R.W., Glover E., Pitot H.C., McElwee M.K., Bradfield C.A. The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol. Pharmacol. 2005, 67:714-720.
25. McMillan B.J., Bradfield C.A. The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol. Pharmacol. 2007, 72:487-498.
26. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., Caccamo M., Oukka M., Weiner H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
27. Velhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., Stockinger B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
28. Kimura A., Naka T., Nohara K., Fujii-Kuriyama Y., Kishimoto T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9721-9726.
29. Stevens E.A., Mezrich J.D., Bradfield C.A. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 2009, 127:299-311.
30. Head J.L., Lawrence B.P. The aryl hydrocarbon receptor is a modulator of anti-viral immunity. Biochem. Pharmacol. 2009, 77:642-653.
31. Shi L.Z., Faith N.G., Nakayama Y., Suresh M., Steinberg H., Czuprynski C.J. The aryl hydrocarbon receptor is required for optimal resistance to Listeria monocytogenes infection in mice. J. Immunol. 2007, 179:65-71.
32. Fingerhut M.A., Halperin W.E., Marlow D.A. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N. Engl. J. Med. 1991, 324:212-218.
33. IARC working group on the evaluation of carcinogenic risks to humans: polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC Monogr. Eval. Carcinog. Risks Hum. 1997, 69:1-631.
34. Bertazzi P.A., Pesatori A.C., Bernucci I., Landt M.T., Consonni C. Dioxin exposure and human leukemias and lymphomas. Lessons from the Seveso accident and studies on industrial workers. Leukemia 1999, 133(Suppl. 1):S72-S74.
35. Baccarell A., Morarelli P., Patterson D.G., Bonzini M., Pesatori A.C., Caporaso N., Landt M.T. Immunologic effects of dioxin: new results from Seveso and comparison to other studies. Environ. Health Perspect. 2002, 110:1169-1173.
36. Zheng T., Blair A., Zhang Y., Weisenburger D.D., Zahm A. Occupation and risks of non-Hodgkin's lymphoma and chronic lymphocytic leukemia. J. Occup. Environ. Med. 2002, 44:469-474.
37. Magnani C., Pastore G., Luzzatto L., Terracini B. Parental occupation and other environmental factors in the etiology of leukemias and non-Hodgkin's lymphoma in childhood: a case-control study. Tumori 1990, 76:413-419.
38. Filippini G., Farinotti M., Ferrarini M. Active and passive smoking during pregnancy and risk of central nervous system tumors in children. Paediatr. Perinat. Epidemiol. 2000, 14:78-84.
39. Gebremichael A., Tullis K., Denison M.S., Cheek J.M., Pinkerton K.E. Ah-receptor-dependent modulation of gene expression by aged and diluted sidestream cigarette smoke. Toxicol. Appl. Pharmacol. 1996, 141:76-83.
40. Dertinger S.D., Nazarenko D.A., Silverstone A.E., Gasiewicz T.A. Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensate-induced cytogenetic damage in vivo. Carcinogenesis 2001, 22:171-177.
41. Fine J.S., Gasiewicz T.A., Fiore N.C., Silverstone A.E. Prothymocye activity is reduced by perinatal 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. J. Pharmacol. Exp. Therap. 1990, 255:128-132.
42. Fine J.S., Silverstone A.E., Gasiewicz T.A. Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Immunol. 1990, 144:1169-1176.
43. Staples J.E., Murante F.G., Fiore N.C., Gasiewicz T.A., Silverstone A.E. Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. J. Immunol. 1998, 160:3844-3854.
44. Laiosa M.D., Wyman A., Murante F.G., Fiore N.C., Staples J.E., Gasiewicz T.A., Silverstone A.E. Cell proliferation arrest within intrathymic lymphocyte progenitor cells causes thymic atrophy mediated by the aryl hydrocarbon receptor. J. Immunol. 2003, 171:4582-4591.
45. Thurmond T.S., Gasiewicz T.A. A single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin produces a time- and dose-dependent alteration in the murine bone marrow B-lymphocyte maturation profile. Toxicol. Sci. 2000, 58:88-95.
46. Murante F.G., Gasiewicz T.A. Hemopoietic progenitor cells are sensitive targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J mice. Toxicol. Sci. 2000, 54:374-383.
47. Garrett R.W., Gasiewicz T.A. The aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin alters the circadian rhythms, quiescence, and expression of clock genes in murine hematopoietic stem and progenitor cells. Mol. Pharmacol. 2006, 69:2076-2083.
48. Sakai R., Kajiume T., Inoue H., Kanno R., Miyazaki M., Ninomiya Y., Kanno M. TCDD treatment eliminates the long-term reconstitution activity of hematopoietic stem cells. Toxicol. Sci. 2003, 72:84-91.
49. Fleming W.H., Alpern E.J., Uchida N., Ikuta K., Spangrude G.J., Weissman I.L. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J. Cell. Biol. 1993, 122:897-902.
50. Jetmore A., Plet P.A., Tong X., Wolber F.M., Breese R., Abonour R., Orschell-Traycoff C.M., Srour E.F. Homing efficiency, cell cycle kinetics and survival of quiescent and cycling human CD34(+) cells transplanted into conditional NOD/SCID recipients. Blood 2002, 99:1585-1593.
51. - cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 2000, 96:1380-1387.
52. Gasiewicz T.A., Henry E.C., Collins L.L. Expression and activity of aryl hydrocarbon receptors in development and cancer. Crit. Rev. Eukaryotic Gene Exp. 2008, 18:279-321.
53. Sartor M.A., Schnekenburger M., Marlowe J.L., Reichard J.F., Wang Y., Fan Y., Ma C., Karyala S., Halbleib D., Liu X., Medvedovic M., Puga A. Genome wide analysis of aryl hydrocarbon receptor binding sites reveals an extensive array of gene clusters that control morphogenetic and developmental patterns. Environ. Health Perspect. 2009, 117:1139-1146.
54. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
55. Kim D.W., Gazourian L., Quadri S.A., Romieu-Mourez R., Sherr D.H. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 2000, 19:5498-5506.
56. Thomsen J.S., Keitz S., Strom A., Gustafsson J.-A. HES-1, a novel target gene for the aryl hydrocarbon receptor. Mol. Pharmacol. 2004, 65:165-171.
57. Terskikh A.V., Miyamoto T., Chang C., Diatchenko L., Weissman I.L. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 2003, 102:94-101.
58. Bruno L., Hoffman R., McBlane F., Brown J., Gupta R., Joshi C. Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. Mol. Cell. Biol. 2004, 24:741-756.
59. Sang L., Coller H.A., Roberts J.M. Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 2008, 321:1095-1100.
60. Harper P.A., Riddick D.S., Okey A.B. Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem. Pharmacol. 2006, 72:267-279.
61. Mitchell K.A., Elferink C.J. Timing is everything: consequences of transient and sustained AhR activity. Biochem. Pharmacol. 2009, 77:947-956.
62. Pollenz R.S. The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 1996, 49:391-398.
63. Davarinos N.A., Pollenz R.S. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytoplasmic proteasome following nuclear export. J. Biol. Chem. 1999, 274:28708-28715.
64. Roberts B.J., Whitelaw M.L. Degradation of the basic helix-loop-helix/Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway. J. Biol. Chem. 1999, 274:36351-36356.
65. Mimura J., Ema M., Sogawa K., Fujii-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev. 1999, 13:20-25.
66. Evans B.R., Karchner S.I., Allan L.L., Pollenz R.S., Tanguay R.L., Jenny M.J., Sherr D.H., Hahn M.E. Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator. Mol. Pharmcol. 2008, 73:387-398.
67. Hesterman E.V., Stegeman J.J., Hahn M.E. Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. Toxicol. Appl. Pharmacol. 2000, 168:160-172.
68. Henry E.C., Gasiewicz T.A. Agonist but not antagonist ligands induce conformational changes in the mouse aryl hydrocarbon receptor as detected by partial proteolysis. Mol. Pharmacol. 2003, 63:392-400.
69. Venezia T.A., Merchant A.A., Ramos C.A., Whitehouse N.L., Young A.S., Shaw C.A., Goodell M.A. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol. 2004, 2:1640-1651.
70. + lineage marker-cell population. Stem Cells 2008, 26:646-655.
71. Mulero-Navarro S., Carvajal-Gonzalez J.M., Herranz M., Ballesar E., Fraga M.F., Ropero S., Esteller M., Fernandez-Salguero P.M. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. Carcinogenesis 2006, 27:1099-1104.
72. de Haan G., Nijhof W., Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood 1997, 89:1543-1550.
73. Sudo K., Ema H., Morita Y., Nakauchi H. Age-associated characteristics of murine hematopoietic stem cells. J. Exp. Med. 2000, 192:1273-1280.
74. de Haan G., Van Zant G. Genetic analysis of hemopoietic cell cycling in mice suggests its involvement in organismal life span. FASEB J. 1999, 13:707-713.
75. Nebert D.W., Brown D.D., Towne D.W., Eisen H.J. Association of fertility, fitness, and longevity with the murine Ah locus among (C57BL/6N) (C3H/HeN) recombinant inbred strains. Biol. Reprod. 1984, 30:363-373.
76. Spindler S.R., Koizumi A., Walford R.L., Mote P.L. P1-450 and P3-450 gene expression and maximum life span in mice. Mut. Res. 1996, 219:1011-1016.
77. de Haan G., Van Zant G. Dynamic changes in mouse hematopoietic stem cell numbers during aging. Blood 1999, 93:790-7296.
78. Morrison S.J., Wandycz A.M., Akashi K., Globerson A., Weissman I.L. The aging of hematopoietic stem cells. Nat. Med. 1996, 2:1011-1016.
79. Chen J. Senescence and functional failure in hematopoietic stem cells. Exp. Hematol. 2004, 32:1025-1032.
80. Kim M., Moon H.B., Spangrude G.J. Major age-related changes of mouse hematopoietic stem/progenitor cells. Ann. N. Y. Acad. Sci. 2003, 996:195-208.
81. Van Zant G., Liang Y. The role of stem cells in aging. Exp. Hematol. 2003, 31:659-672.
82. Bell D.R., Van Zant G. Stem cells, aging and cancer: inevitabilities and outcomes. Oncogene 2004, 23:7290-7296.
83. Morse H.C., Anver M.R, Fredrickson T.N., Haines D.C., Harris A.W., Harris N.L., Jaffe E.S., Kogan S.C., MacLennan I.C.M., Pettengale P.K., Ward J.M. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 2002, 100:246-258.
84. Karsunky H., Zeng H., Schmidt T., Zevnik B., Kluge R., Shmid K.W., Duhrsen U., Moroy T. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat. Genet. 2002, 30:295-300.
85. Shimizu R., Kuroha T., Ohneda O., Pan X., Ohneda K., Takahashi S., Philipsen S., Yamamoto M. Leukemogenesis caused by incapacitated GATA-1 function. Mol. Cell. Biol. 2004, 24:10814-10825.
86. Jacob B., Osato M. Stem cell exhaustion and leukemogenesis. J. Cell. Biochem. 2009, 107:393-399.
87. Hirabayashi Y., Yoon B.I., Fujii-Kuriyama Y., Kaneko T., Kanno J., Inoue T. Tumor suppressor function of aryl hydrocarbon receptor (AhR): early onset of spontaneous lymphoma and hepatoma, and resulting shortened life span observed in AhR deficient mice. Organohal. Comd. 2006, 68:556-559.